Surface Oncology, Inc.
SURFDelisted Sep 8, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001718108
Surface Oncology, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Sep 8, 2023; 62 institutions reported holding it in 13F filings for Q2 2023, worth $16.9M in total; ARK Invest was the only superinvestor holding it.
Holders of 5% or more of SURF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Surface Oncology, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Surface Oncology, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Surface Oncology, Inc., newest first.
No Schedule 13D or 13G filings on Surface Oncology, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Surface Oncology, Inc. shares.
No Form 144 notices for Surface Oncology, Inc. are on file.